Glycoprotein G enables HSV-2 neuroinvasion and provides protection as a glycosylated vaccine antigen
PLOS Pathogens · 09.07.2026 · 22 (7) · e1014339
DOI: 10.1371/journal.ppat.1014339 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 09.07.2026. Verfasst von Ebba Könighofer und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Herpesvirus 2, Human, Herpes Genitalis, Viral Envelope Proteins, Antigens, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sweden’s innovation agency Vinnova, ALF Foundation of Sahlgrenska University Hospital, VINNOVA.
Abstract (Originalsprache)
The role of glycoprotein G (gG-2) of herpes simplex virus type 2 (HSV-2) in viral pathogenesis remains poorly understood. gG-2 is cleaved into a secreted form (sgG-2) and a membrane-associated form (mgG-2), but the in vivo function of mgG-2 and the contribution of its glycosylation to immune responses have not been defined. Here, we provide a comprehensive characterization of the N- and O-linked glycosylation profile of mgG-2 and investigate its functional relevance for viral spread and vaccine-induced immunity. Using a mouse genital infection model, we show that an mgG-2-deficient HSV-2 mutant replicates in vaginal epithelial cells but is severely impaired in dissemination to dorsal root ganglia and the central nervous system, identifying mgG-2 as a key determinant of neuronal spread in vivo. In parallel, immunization with recombinant mgG-2 elicited strong humoral and Th1-polarized CD4 + T-cell responses and conferred protection against genital HSV-2 challenge. Importantly, glycosylation of mgG-2 was required for optimal immunogenicity and protection, as deglycosylated variants induced reduced CD4 + T-cell responses and allowed increased viral spread to neuronal tissues. Mechanistically, our findings suggest that glycosylation of mgG-2 modulates antigen recognition and shapes adaptive immune responses that limit viral dissemination after vaccination. Together, these results demonstrate that mgG-2 plays a critical role in HSV-2 pathogenesis and provide a strong rationale for targeting glycosylated mgG-2 in the development of both prophylactic and therapeutic vaccines against HSV-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Clinical microbiology, Sahlgrenska University Hospital, Västra Götalandsregionen, Sweden.
- Simplexia AB, Gothenburg, Sweden.
- Proteomics Core Facility, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
ORCID-Profile: Ebba Könighofer
Förderung
- Sweden’s innovation agency Vinnova
- ALF Foundation of Sahlgrenska University Hospital
- VINNOVA
Zitieren
APA
Könighofer, E., Gustafsson, C., Gudmundsdotter, L., Mirgorodskaya, E., Nilsson, J., Ekblad, M., Adamiak, B., Jennische, E., Lange, S., Trybala, E., Görander, S., Bergström, T., Liljeqvist, J. Å., & Nordén, R. (2026). Glycoprotein G enables HSV-2 neuroinvasion and provides protection as a glycosylated vaccine antigen. PLOS Pathogens, 22(7), e1014339. https://doi.org/10.1371/journal.ppat.1014339
Vancouver
Könighofer E, Gustafsson C, Gudmundsdotter L, Mirgorodskaya E, Nilsson J, Ekblad M, et al. Glycoprotein G enables HSV-2 neuroinvasion and provides protection as a glycosylated vaccine antigen. PLOS Pathogens. 2026;22(7):e1014339. doi:10.1371/journal.ppat.1014339
BibTeX
@article{Knighofer2026,
author = {Könighofer, Ebba and Gustafsson, Carolina and Gudmundsdotter, Lindvi and Mirgorodskaya, Ekaterina and Nilsson, Jonas and Ekblad, Maria and Adamiak, Beata and Jennische, Eva and Lange, Stefan and Trybala, Edward and Görander, Staffan and Bergström, Tomas and Liljeqvist, Jan-Åke and Nordén, Rickard},
title = {Glycoprotein G enables HSV-2 neuroinvasion and provides protection as a glycosylated vaccine antigen},
journal = {PLOS Pathogens},
year = {2026},
volume = {22},
number = {7},
pages = {e1014339},
doi = {10.1371/journal.ppat.1014339}
}
EUVIMED